Literature DB >> 10675327

Crystal structure of a class I alpha1,2-mannosidase involved in N-glycan processing and endoplasmic reticulum quality control.

F Vallée1, F Lipari, P Yip, B Sleno, A Herscovics, P L Howell.   

Abstract

Mannose trimming is not only essential for N-glycan maturation in mammalian cells but also triggers degradation of misfolded glycoproteins. The crystal structure of the class I alpha1, 2-mannosidase that trims Man(9)GlcNAc(2) to Man(8)GlcNAc(2 )isomer B in the endoplasmic reticulum of Saccharomyces cerevisiae reveals a novel (alphaalpha)(7)-barrel in which an N-glycan from one molecule extends into the barrel of an adjacent molecule, interacting with the essential acidic residues and calcium ion. The observed protein-carbohydrate interactions provide the first insight into the catalytic mechanism and specificity of this eukaryotic enzyme family and may be used to design inhibitors that prevent degradation of misfolded glycoproteins in genetic diseases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10675327      PMCID: PMC305596          DOI: 10.1093/emboj/19.4.581

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  45 in total

1.  Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons.

Authors:  A Nicholls; K A Sharp; B Honig
Journal:  Proteins       Date:  1991

2.  Crystal structure of protein farnesyltransferase at 2.25 angstrom resolution.

Authors:  H W Park; S R Boduluri; J F Moomaw; P J Casey; L S Beese
Journal:  Science       Date:  1997-03-21       Impact factor: 47.728

3.  Crystallization and preliminary X-ray analysis of the class 1 alpha 1,2-mannosidase from Saccharomyces cerevisiae.

Authors:  K Dole; F Lipari; A Herscovics; P L Howell
Journal:  J Struct Biol       Date:  1997-10       Impact factor: 2.867

4.  Substrate specificities of recombinant murine Golgi alpha1, 2-mannosidases IA and IB and comparison with endoplasmic reticulum and Golgi processing alpha1,2-mannosidases.

Authors:  A Lal; P Pang; S Kalelkar; P A Romero; A Herscovics; K W Moremen
Journal:  Glycobiology       Date:  1998-10       Impact factor: 4.313

Review 5.  Processing glycosidases of Saccharomyces cerevisiae.

Authors:  A Herscovics
Journal:  Biochim Biophys Acta       Date:  1999-01-06

6.  Site-directed mutagenesis of the catalytic base glutamic acid 400 in glucoamylase from Aspergillus niger and of tyrosine 48 and glutamine 401, both hydrogen-bonded to the gamma-carboxylate group of glutamic acid 400.

Authors:  T P Frandsen; C Dupont; J Lehmbeck; B Stoffer; M R Sierks; R B Honzatko; B Svensson
Journal:  Biochemistry       Date:  1994-11-22       Impact factor: 3.162

7.  Evidence for an alpha-mannosidase in endoplasmic reticulum of rat liver.

Authors:  J Bischoff; R Kornfeld
Journal:  J Biol Chem       Date:  1983-07-10       Impact factor: 5.157

8.  Glycoprotein synthesis in yeast. Identification of Man8GlcNAc2 as an essential intermediate in oligosaccharide processing.

Authors:  J C Byrd; A L Tarentino; F Maley; P H Atkinson; R B Trimble
Journal:  J Biol Chem       Date:  1982-12-25       Impact factor: 5.157

9.  Demonstration that a kifunensine-resistant alpha-mannosidase with a unique processing action on N-linked oligosaccharides occurs in rat liver endoplasmic reticulum and various cultured cells.

Authors:  S Weng; R G Spiro
Journal:  J Biol Chem       Date:  1993-12-05       Impact factor: 5.157

Review 10.  Biological roles of oligosaccharides: all of the theories are correct.

Authors:  A Varki
Journal:  Glycobiology       Date:  1993-04       Impact factor: 4.313

View more
  24 in total

1.  Redundancy, antiredundancy, and the robustness of genomes.

Authors:  David C Krakauer; Joshua B Plotkin
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

2.  So what do your sugars do?

Authors:  R C Hughes
Journal:  Glycoconj J       Date:  2000 Jul-Sep       Impact factor: 2.916

3.  Stabilized HIV-1 envelope glycoprotein trimers lacking the V1V2 domain, obtained by virus evolution.

Authors:  Ilja Bontjer; Mark Melchers; Dirk Eggink; Kathryn David; John P Moore; Ben Berkhout; Rogier W Sanders
Journal:  J Biol Chem       Date:  2010-09-08       Impact factor: 5.157

4.  Analysis of site-specific N-glycan remodeling in the endoplasmic reticulum and the Golgi.

Authors:  Ivan Hang; Chia-wei Lin; Oliver C Grant; Susanna Fleurkens; Thomas K Villiger; Miroslav Soos; Massimo Morbidelli; Robert J Woods; Robert Gauss; Markus Aebi
Journal:  Glycobiology       Date:  2015-08-03       Impact factor: 4.313

5.  Family 47 alpha-mannosidases in N-glycan processing.

Authors:  Steven W Mast; Kelley W Moremen
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

6.  Htm1p-Pdi1p is a folding-sensitive mannosidase that marks N-glycoproteins for ER-associated protein degradation.

Authors:  Yi-Chang Liu; Danica Galonić Fujimori; Jonathan S Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-28       Impact factor: 11.205

7.  A Golgi-localized mannosidase (MAN1B1) plays a non-enzymatic gatekeeper role in protein biosynthetic quality control.

Authors:  Michael J Iannotti; Lauren Figard; Anna M Sokac; Richard N Sifers
Journal:  J Biol Chem       Date:  2014-03-13       Impact factor: 5.157

8.  Structure of Golgi alpha-mannosidase II: a target for inhibition of growth and metastasis of cancer cells.

Authors:  J M van den Elsen; D A Kuntz; D R Rose
Journal:  EMBO J       Date:  2001-06-15       Impact factor: 11.598

9.  Characterization of Schizosaccharomyces pombe ER alpha-mannosidase: a reevaluation of the role of the enzyme on ER-associated degradation.

Authors:  Federico Movsichoff; Olga A Castro; Armando J Parodi
Journal:  Mol Biol Cell       Date:  2005-08-03       Impact factor: 4.138

10.  Functional analysis of an alpha-1,2-mannosidase from Magnaporthe oryzae.

Authors:  Jie Zhou; Cheng-zeng Lin; Xiang-zi Zheng; Xiong-jie Lin; Wei-jian Sang; Shi-hua Wang; Zong-hua Wang; Daniel Ebbole; Guo-dong Lu
Journal:  Curr Genet       Date:  2009-07-21       Impact factor: 3.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.